Abzena, the integrated CDMO and CRO specializing in complex biologics [...]

Neuraxpharm Group, a leading European specialty pharmaceutical company focused on [...]

Scancell has reported updated results from its Phase 2 SCOPE [...]

The US Food and Drug Administration’s (FDA) decision to phase [...]

Corteria Pharmaceuticals has launched a Phase 2 trial of its [...]

Sanofi has agreed to acquire Vicebio Ltd, a biotechnology company [...]

The pharmaceutical sector is accelerating into an enterprise-scale AI future, [...]

Morphic Medical’s non-invasive weight loss device RESET is expected to [...]

DiaMedica Therapeutics Inc has announced positive interim results from Part [...]

Mainz Biomed says it is preparing to launch a pivotal [...]